世界の腫瘍個別化医療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Personalized Medicines In Oncology Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4692 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、腫瘍個別化医療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（分子腫瘍病理学、ゲノム診断、放射線療法、腫瘍検査、化学療法、その他）、用途別市場規模（研究センター、政府機関、病院、臨床センター、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・腫瘍個別化医療の市場動向 ・企業の競争状況、市場シェア ・腫瘍個別化医療の種類別市場規模と予測2016-2027（分子腫瘍病理学、ゲノム診断、放射線療法、腫瘍検査、化学療法、その他） ・腫瘍個別化医療の用途別市場規模と予測2016-2027（研究センター、政府機関、病院、臨床センター、その他） ・腫瘍個別化医療の北米市場規模2016-2027（アメリカ、カナダ） ・腫瘍個別化医療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・腫瘍個別化医療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・腫瘍個別化医療の中南米市場規模2016-2027（メキシコ、ブラジル） ・腫瘍個別化医療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Biotheranostics、Illumina、DNA Link、Genomic Health, Inc.(Exact Sciences)、Cypher Genomics(Human Longevity, Inc.)、Life Technologies Corporation(Thermo Fisher Scientific)、Fulgent Genetics、Caris Life Sciences、Ariana Pharma、Abbott Laboratories、deCODE genetics、Exagen Inc） ・結論

Oncology is a type of medicine that refers to the diagnosis, treatment and prevention of different types of cancers like blood cancer, skin cancer, breast cancer, lung cancer and others.

Market Analysis and Insights: Global Personalized Medicines In Oncology Market
The global Personalized Medicines In Oncology market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Personalized Medicines In Oncology market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Personalized Medicines In Oncology market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Personalized Medicines In Oncology market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Personalized Medicines In Oncology market.

Global Personalized Medicines In Oncology Scope and Market Size
Personalized Medicines In Oncology market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Personalized Medicines In Oncology market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Molecular Oncopathology
Genome Diagnostics
Radiation Therapy
Oncology Testing
Chemotherapy
Others

Segment by Application
Research Centers
Governmental Institutions
Hospitals
Clinical Centers
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Biotheranostics
Illumina
DNA Link
Genomic Health, Inc.(Exact Sciences)
Cypher Genomics(Human Longevity, Inc.)
Life Technologies Corporation(Thermo Fisher Scientific)
Fulgent Genetics
Caris Life Sciences
Ariana Pharma
Abbott Laboratories
deCODE genetics
Exagen Inc

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Personalized Medicines In Oncology Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Molecular Oncopathology
1.2.3 Genome Diagnostics
1.2.4 Radiation Therapy
1.2.5 Oncology Testing
1.2.6 Chemotherapy
1.2.7 Others
1.3 Market by Application
1.3.1 Global Personalized Medicines In Oncology Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Research Centers
1.3.3 Governmental Institutions
1.3.4 Hospitals
1.3.5 Clinical Centers
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Personalized Medicines In Oncology Market Perspective (2016-2027)
2.2 Personalized Medicines In Oncology Growth Trends by Regions
2.2.1 Personalized Medicines In Oncology Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Personalized Medicines In Oncology Historic Market Share by Regions (2016-2021)
2.2.3 Personalized Medicines In Oncology Forecasted Market Size by Regions (2022-2027)
2.3 Personalized Medicines In Oncology Industry Dynamic
2.3.1 Personalized Medicines In Oncology Market Trends
2.3.2 Personalized Medicines In Oncology Market Drivers
2.3.3 Personalized Medicines In Oncology Market Challenges
2.3.4 Personalized Medicines In Oncology Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Personalized Medicines In Oncology Players by Revenue
3.1.1 Global Top Personalized Medicines In Oncology Players by Revenue (2016-2021)
3.1.2 Global Personalized Medicines In Oncology Revenue Market Share by Players (2016-2021)
3.2 Global Personalized Medicines In Oncology Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Personalized Medicines In Oncology Revenue
3.4 Global Personalized Medicines In Oncology Market Concentration Ratio
3.4.1 Global Personalized Medicines In Oncology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Personalized Medicines In Oncology Revenue in 2020
3.5 Personalized Medicines In Oncology Key Players Head office and Area Served
3.6 Key Players Personalized Medicines In Oncology Product Solution and Service
3.7 Date of Enter into Personalized Medicines In Oncology Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Personalized Medicines In Oncology Breakdown Data by Type
4.1 Global Personalized Medicines In Oncology Historic Market Size by Type (2016-2021)
4.2 Global Personalized Medicines In Oncology Forecasted Market Size by Type (2022-2027)

5 Personalized Medicines In Oncology Breakdown Data by Application
5.1 Global Personalized Medicines In Oncology Historic Market Size by Application (2016-2021)
5.2 Global Personalized Medicines In Oncology Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Personalized Medicines In Oncology Market Size (2016-2027)
6.2 North America Personalized Medicines In Oncology Market Size by Type
6.2.1 North America Personalized Medicines In Oncology Market Size by Type (2016-2021)
6.2.2 North America Personalized Medicines In Oncology Market Size by Type (2022-2027)
6.2.3 North America Personalized Medicines In Oncology Market Size by Type (2016-2027)
6.3 North America Personalized Medicines In Oncology Market Size by Application
6.3.1 North America Personalized Medicines In Oncology Market Size by Application (2016-2021)
6.3.2 North America Personalized Medicines In Oncology Market Size by Application (2022-2027)
6.3.3 North America Personalized Medicines In Oncology Market Size by Application (2016-2027)
6.4 North America Personalized Medicines In Oncology Market Size by Country
6.4.1 North America Personalized Medicines In Oncology Market Size by Country (2016-2021)
6.4.2 North America Personalized Medicines In Oncology Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Personalized Medicines In Oncology Market Size (2016-2027)
7.2 Europe Personalized Medicines In Oncology Market Size by Type
7.2.1 Europe Personalized Medicines In Oncology Market Size by Type (2016-2021)
7.2.2 Europe Personalized Medicines In Oncology Market Size by Type (2022-2027)
7.2.3 Europe Personalized Medicines In Oncology Market Size by Type (2016-2027)
7.3 Europe Personalized Medicines In Oncology Market Size by Application
7.3.1 Europe Personalized Medicines In Oncology Market Size by Application (2016-2021)
7.3.2 Europe Personalized Medicines In Oncology Market Size by Application (2022-2027)
7.3.3 Europe Personalized Medicines In Oncology Market Size by Application (2016-2027)
7.4 Europe Personalized Medicines In Oncology Market Size by Country
7.4.1 Europe Personalized Medicines In Oncology Market Size by Country (2016-2021)
7.4.2 Europe Personalized Medicines In Oncology Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Personalized Medicines In Oncology Market Size (2016-2027)
8.2 Asia-Pacific Personalized Medicines In Oncology Market Size by Type
8.2.1 Asia-Pacific Personalized Medicines In Oncology Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Personalized Medicines In Oncology Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Personalized Medicines In Oncology Market Size by Type (2016-2027)
8.3 Asia-Pacific Personalized Medicines In Oncology Market Size by Application
8.3.1 Asia-Pacific Personalized Medicines In Oncology Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Personalized Medicines In Oncology Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Personalized Medicines In Oncology Market Size by Application (2016-2027)
8.4 Asia-Pacific Personalized Medicines In Oncology Market Size by Region
8.4.1 Asia-Pacific Personalized Medicines In Oncology Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Personalized Medicines In Oncology Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Personalized Medicines In Oncology Market Size (2016-2027)
9.2 Latin America Personalized Medicines In Oncology Market Size by Type
9.2.1 Latin America Personalized Medicines In Oncology Market Size by Type (2016-2021)
9.2.2 Latin America Personalized Medicines In Oncology Market Size by Type (2022-2027)
9.2.3 Latin America Personalized Medicines In Oncology Market Size by Type (2016-2027)
9.3 Latin America Personalized Medicines In Oncology Market Size by Application
9.3.1 Latin America Personalized Medicines In Oncology Market Size by Application (2016-2021)
9.3.2 Latin America Personalized Medicines In Oncology Market Size by Application (2022-2027)
9.3.3 Latin America Personalized Medicines In Oncology Market Size by Application (2016-2027)
9.4 Latin America Personalized Medicines In Oncology Market Size by Country
9.4.1 Latin America Personalized Medicines In Oncology Market Size by Country (2016-2021)
9.4.2 Latin America Personalized Medicines In Oncology Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Personalized Medicines In Oncology Market Size (2016-2027)
10.2 Middle East & Africa Personalized Medicines In Oncology Market Size by Type
10.2.1 Middle East & Africa Personalized Medicines In Oncology Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Personalized Medicines In Oncology Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Personalized Medicines In Oncology Market Size by Type (2016-2027)
10.3 Middle East & Africa Personalized Medicines In Oncology Market Size by Application
10.3.1 Middle East & Africa Personalized Medicines In Oncology Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Personalized Medicines In Oncology Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Personalized Medicines In Oncology Market Size by Application (2016-2027)
10.4 Middle East & Africa Personalized Medicines In Oncology Market Size by Country
10.4.1 Middle East & Africa Personalized Medicines In Oncology Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Personalized Medicines In Oncology Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Biotheranostics
11.1.1 Biotheranostics Company Details
11.1.2 Biotheranostics Business Overview
11.1.3 Biotheranostics Personalized Medicines In Oncology Introduction
11.1.4 Biotheranostics Revenue in Personalized Medicines In Oncology Business (2016-2021)
11.1.5 Biotheranostics Recent Development
11.2 Illumina
11.2.1 Illumina Company Details
11.2.2 Illumina Business Overview
11.2.3 Illumina Personalized Medicines In Oncology Introduction
11.2.4 Illumina Revenue in Personalized Medicines In Oncology Business (2016-2021)
11.2.5 Illumina Recent Development
11.3 DNA Link
11.3.1 DNA Link Company Details
11.3.2 DNA Link Business Overview
11.3.3 DNA Link Personalized Medicines In Oncology Introduction
11.3.4 DNA Link Revenue in Personalized Medicines In Oncology Business (2016-2021)
11.3.5 DNA Link Recent Development
11.4 Genomic Health, Inc.(Exact Sciences)
11.4.1 Genomic Health, Inc.(Exact Sciences) Company Details
11.4.2 Genomic Health, Inc.(Exact Sciences) Business Overview
11.4.3 Genomic Health, Inc.(Exact Sciences) Personalized Medicines In Oncology Introduction
11.4.4 Genomic Health, Inc.(Exact Sciences) Revenue in Personalized Medicines In Oncology Business (2016-2021)
11.4.5 Genomic Health, Inc.(Exact Sciences) Recent Development
11.5 Cypher Genomics(Human Longevity, Inc.)
11.5.1 Cypher Genomics(Human Longevity, Inc.) Company Details
11.5.2 Cypher Genomics(Human Longevity, Inc.) Business Overview
11.5.3 Cypher Genomics(Human Longevity, Inc.) Personalized Medicines In Oncology Introduction
11.5.4 Cypher Genomics(Human Longevity, Inc.) Revenue in Personalized Medicines In Oncology Business (2016-2021)
11.5.5 Cypher Genomics(Human Longevity, Inc.) Recent Development
11.6 Life Technologies Corporation(Thermo Fisher Scientific)
11.6.1 Life Technologies Corporation(Thermo Fisher Scientific) Company Details
11.6.2 Life Technologies Corporation(Thermo Fisher Scientific) Business Overview
11.6.3 Life Technologies Corporation(Thermo Fisher Scientific) Personalized Medicines In Oncology Introduction
11.6.4 Life Technologies Corporation(Thermo Fisher Scientific) Revenue in Personalized Medicines In Oncology Business (2016-2021)
11.6.5 Life Technologies Corporation(Thermo Fisher Scientific) Recent Development
11.7 Fulgent Genetics
11.7.1 Fulgent Genetics Company Details
11.7.2 Fulgent Genetics Business Overview
11.7.3 Fulgent Genetics Personalized Medicines In Oncology Introduction
11.7.4 Fulgent Genetics Revenue in Personalized Medicines In Oncology Business (2016-2021)
11.7.5 Fulgent Genetics Recent Development
11.8 Caris Life Sciences
11.8.1 Caris Life Sciences Company Details
11.8.2 Caris Life Sciences Business Overview
11.8.3 Caris Life Sciences Personalized Medicines In Oncology Introduction
11.8.4 Caris Life Sciences Revenue in Personalized Medicines In Oncology Business (2016-2021)
11.8.5 Caris Life Sciences Recent Development
11.9 Ariana Pharma
11.9.1 Ariana Pharma Company Details
11.9.2 Ariana Pharma Business Overview
11.9.3 Ariana Pharma Personalized Medicines In Oncology Introduction
11.9.4 Ariana Pharma Revenue in Personalized Medicines In Oncology Business (2016-2021)
11.9.5 Ariana Pharma Recent Development
11.10 Abbott Laboratories
11.10.1 Abbott Laboratories Company Details
11.10.2 Abbott Laboratories Business Overview
11.10.3 Abbott Laboratories Personalized Medicines In Oncology Introduction
11.10.4 Abbott Laboratories Revenue in Personalized Medicines In Oncology Business (2016-2021)
11.10.5 Abbott Laboratories Recent Development
11.11 deCODE genetics
11.11.1 deCODE genetics Company Details
11.11.2 deCODE genetics Business Overview
11.11.3 deCODE genetics Personalized Medicines In Oncology Introduction
11.11.4 deCODE genetics Revenue in Personalized Medicines In Oncology Business (2016-2021)
11.11.5 deCODE genetics Recent Development
11.12 Exagen Inc
11.12.1 Exagen Inc Company Details
11.12.2 Exagen Inc Business Overview
11.12.3 Exagen Inc Personalized Medicines In Oncology Introduction
11.12.4 Exagen Inc Revenue in Personalized Medicines In Oncology Business (2016-2021)
11.12.5 Exagen Inc Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Personalized Medicines In Oncology Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Molecular Oncopathology
Table 3. Key Players of Genome Diagnostics
Table 4. Key Players of Radiation Therapy
Table 5. Key Players of Oncology Testing
Table 6. Key Players of Chemotherapy
Table 7. Key Players of Others
Table 8. Global Personalized Medicines In Oncology Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Personalized Medicines In Oncology Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Personalized Medicines In Oncology Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Personalized Medicines In Oncology Market Share by Regions (2016-2021)
Table 12. Global Personalized Medicines In Oncology Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Personalized Medicines In Oncology Market Share by Regions (2022-2027)
Table 14. Personalized Medicines In Oncology Market Trends
Table 15. Personalized Medicines In Oncology Market Drivers
Table 16. Personalized Medicines In Oncology Market Challenges
Table 17. Personalized Medicines In Oncology Market Restraints
Table 18. Global Personalized Medicines In Oncology Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Personalized Medicines In Oncology Market Share by Players (2016-2021)
Table 20. Global Top Personalized Medicines In Oncology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Personalized Medicines In Oncology as of 2020)
Table 21. Ranking of Global Top Personalized Medicines In Oncology Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Personalized Medicines In Oncology Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Personalized Medicines In Oncology Product Solution and Service
Table 25. Date of Enter into Personalized Medicines In Oncology Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Personalized Medicines In Oncology Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Personalized Medicines In Oncology Revenue Market Share by Type (2016-2021)
Table 29. Global Personalized Medicines In Oncology Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Personalized Medicines In Oncology Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Personalized Medicines In Oncology Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Personalized Medicines In Oncology Revenue Market Share by Application (2016-2021)
Table 33. Global Personalized Medicines In Oncology Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Personalized Medicines In Oncology Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Personalized Medicines In Oncology Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Personalized Medicines In Oncology Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Personalized Medicines In Oncology Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Personalized Medicines In Oncology Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Personalized Medicines In Oncology Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Personalized Medicines In Oncology Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Personalized Medicines In Oncology Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Personalized Medicines In Oncology Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Personalized Medicines In Oncology Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Personalized Medicines In Oncology Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Personalized Medicines In Oncology Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Personalized Medicines In Oncology Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Personalized Medicines In Oncology Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Personalized Medicines In Oncology Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Personalized Medicines In Oncology Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Personalized Medicines In Oncology Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Personalized Medicines In Oncology Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Personalized Medicines In Oncology Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Personalized Medicines In Oncology Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Personalized Medicines In Oncology Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Personalized Medicines In Oncology Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Personalized Medicines In Oncology Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Personalized Medicines In Oncology Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Personalized Medicines In Oncology Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Personalized Medicines In Oncology Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Personalized Medicines In Oncology Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Personalized Medicines In Oncology Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Personalized Medicines In Oncology Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Personalized Medicines In Oncology Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Personalized Medicines In Oncology Market Size by Country (2022-2027) & (US$ Million)
Table 65. Biotheranostics Company Details
Table 66. Biotheranostics Business Overview
Table 67. Biotheranostics Personalized Medicines In Oncology Product
Table 68. Biotheranostics Revenue in Personalized Medicines In Oncology Business (2016-2021) & (US$ Million)
Table 69. Biotheranostics Recent Development
Table 70. Illumina Company Details
Table 71. Illumina Business Overview
Table 72. Illumina Personalized Medicines In Oncology Product
Table 73. Illumina Revenue in Personalized Medicines In Oncology Business (2016-2021) & (US$ Million)
Table 74. Illumina Recent Development
Table 75. DNA Link Company Details
Table 76. DNA Link Business Overview
Table 77. DNA Link Personalized Medicines In Oncology Product
Table 78. DNA Link Revenue in Personalized Medicines In Oncology Business (2016-2021) & (US$ Million)
Table 79. DNA Link Recent Development
Table 80. Genomic Health, Inc.(Exact Sciences) Company Details
Table 81. Genomic Health, Inc.(Exact Sciences) Business Overview
Table 82. Genomic Health, Inc.(Exact Sciences) Personalized Medicines In Oncology Product
Table 83. Genomic Health, Inc.(Exact Sciences) Revenue in Personalized Medicines In Oncology Business (2016-2021) & (US$ Million)
Table 84. Genomic Health, Inc.(Exact Sciences) Recent Development
Table 85. Cypher Genomics(Human Longevity, Inc.) Company Details
Table 86. Cypher Genomics(Human Longevity, Inc.) Business Overview
Table 87. Cypher Genomics(Human Longevity, Inc.) Personalized Medicines In Oncology Product
Table 88. Cypher Genomics(Human Longevity, Inc.) Revenue in Personalized Medicines In Oncology Business (2016-2021) & (US$ Million)
Table 89. Cypher Genomics(Human Longevity, Inc.) Recent Development
Table 90. Life Technologies Corporation(Thermo Fisher Scientific) Company Details
Table 91. Life Technologies Corporation(Thermo Fisher Scientific) Business Overview
Table 92. Life Technologies Corporation(Thermo Fisher Scientific) Personalized Medicines In Oncology Product
Table 93. Life Technologies Corporation(Thermo Fisher Scientific) Revenue in Personalized Medicines In Oncology Business (2016-2021) & (US$ Million)
Table 94. Life Technologies Corporation(Thermo Fisher Scientific) Recent Development
Table 95. Fulgent Genetics Company Details
Table 96. Fulgent Genetics Business Overview
Table 97. Fulgent Genetics Personalized Medicines In Oncology Product
Table 98. Fulgent Genetics Revenue in Personalized Medicines In Oncology Business (2016-2021) & (US$ Million)
Table 99. Fulgent Genetics Recent Development
Table 100. Caris Life Sciences Company Details
Table 101. Caris Life Sciences Business Overview
Table 102. Caris Life Sciences Revenue in Personalized Medicines In Oncology Business (2016-2021) & (US$ Million)
Table 103. Caris Life Sciences Recent Development
Table 104. Ariana Pharma Company Details
Table 105. Ariana Pharma Business Overview
Table 106. Ariana Pharma Personalized Medicines In Oncology Product
Table 107. Ariana Pharma Revenue in Personalized Medicines In Oncology Business (2016-2021) & (US$ Million)
Table 108. Ariana Pharma Recent Development
Table 109. Abbott Laboratories Company Details
Table 110. Abbott Laboratories Business Overview
Table 111. Abbott Laboratories Personalized Medicines In Oncology Product
Table 112. Abbott Laboratories Revenue in Personalized Medicines In Oncology Business (2016-2021) & (US$ Million)
Table 113. Abbott Laboratories Recent Development
Table 114. deCODE genetics Company Details
Table 115. deCODE genetics Business Overview
Table 116. deCODE genetics Personalized Medicines In Oncology Product
Table 117. deCODE genetics Revenue in Personalized Medicines In Oncology Business (2016-2021) & (US$ Million)
Table 118. deCODE genetics Recent Development
Table 119. Exagen Inc Company Details
Table 120. Exagen Inc Business Overview
Table 121. Exagen Inc Personalized Medicines In Oncology Product
Table 122. Exagen Inc Revenue in Personalized Medicines In Oncology Business (2016-2021) & (US$ Million)
Table 123. Exagen Inc Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Personalized Medicines In Oncology Market Share by Type: 2020 VS 2027
Figure 2. Molecular Oncopathology Features
Figure 3. Genome Diagnostics Features
Figure 4. Radiation Therapy Features
Figure 5. Oncology Testing Features
Figure 6. Chemotherapy Features
Figure 7. Others Features
Figure 8. Global Personalized Medicines In Oncology Market Share by Application: 2020 VS 2027
Figure 9. Research Centers Case Studies
Figure 10. Governmental Institutions Case Studies
Figure 11. Hospitals Case Studies
Figure 12. Clinical Centers Case Studies
Figure 13. Others Case Studies
Figure 14. Personalized Medicines In Oncology Report Years Considered
Figure 15. Global Personalized Medicines In Oncology Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 16. Global Personalized Medicines In Oncology Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global Personalized Medicines In Oncology Market Share by Regions: 2020 VS 2027
Figure 18. Global Personalized Medicines In Oncology Market Share by Regions (2022-2027)
Figure 19. Global Personalized Medicines In Oncology Market Share by Players in 2020
Figure 20. Global Top Personalized Medicines In Oncology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Personalized Medicines In Oncology as of 2020
Figure 21. The Top 10 and 5 Players Market Share by Personalized Medicines In Oncology Revenue in 2020
Figure 22. Global Personalized Medicines In Oncology Revenue Market Share by Type (2016-2021)
Figure 23. Global Personalized Medicines In Oncology Revenue Market Share by Type (2022-2027)
Figure 24. North America Personalized Medicines In Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. North America Personalized Medicines In Oncology Market Share by Type (2016-2027)
Figure 26. North America Personalized Medicines In Oncology Market Share by Application (2016-2027)
Figure 27. North America Personalized Medicines In Oncology Market Share by Country (2016-2027)
Figure 28. United States Personalized Medicines In Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Canada Personalized Medicines In Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Personalized Medicines In Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Personalized Medicines In Oncology Market Share by Type (2016-2027)
Figure 32. Europe Personalized Medicines In Oncology Market Share by Application (2016-2027)
Figure 33. Europe Personalized Medicines In Oncology Market Share by Country (2016-2027)
Figure 34. Germany Personalized Medicines In Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. France Personalized Medicines In Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. U.K. Personalized Medicines In Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Italy Personalized Medicines In Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Russia Personalized Medicines In Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Nordic Personalized Medicines In Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Personalized Medicines In Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Personalized Medicines In Oncology Market Share by Type (2016-2027)
Figure 42. Asia-Pacific Personalized Medicines In Oncology Market Share by Application (2016-2027)
Figure 43. Asia-Pacific Personalized Medicines In Oncology Market Share by Region (2016-2027)
Figure 44. China Personalized Medicines In Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Japan Personalized Medicines In Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. South Korea Personalized Medicines In Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Southeast Asia Personalized Medicines In Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. India Personalized Medicines In Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Australia Personalized Medicines In Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Personalized Medicines In Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Personalized Medicines In Oncology Market Share by Type (2016-2027)
Figure 52. Latin America Personalized Medicines In Oncology Market Share by Application (2016-2027)
Figure 53. Latin America Personalized Medicines In Oncology Market Share by Country (2016-2027)
Figure 54. Mexico Personalized Medicines In Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Brazil Personalized Medicines In Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Personalized Medicines In Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Personalized Medicines In Oncology Market Share by Type (2016-2027)
Figure 58. Middle East & Africa Personalized Medicines In Oncology Market Share by Application (2016-2027)
Figure 59. Middle East & Africa Personalized Medicines In Oncology Market Share by Country (2016-2027)
Figure 60. Turkey Personalized Medicines In Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Saudi Arabia Personalized Medicines In Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. UAE Personalized Medicines In Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. Biotheranostics Revenue Growth Rate in Personalized Medicines In Oncology Business (2016-2021)
Figure 64. Illumina Revenue Growth Rate in Personalized Medicines In Oncology Business (2016-2021)
Figure 65. DNA Link Revenue Growth Rate in Personalized Medicines In Oncology Business (2016-2021)
Figure 66. Genomic Health, Inc.(Exact Sciences) Revenue Growth Rate in Personalized Medicines In Oncology Business (2016-2021)
Figure 67. Cypher Genomics(Human Longevity, Inc.) Revenue Growth Rate in Personalized Medicines In Oncology Business (2016-2021)
Figure 68. Life Technologies Corporation(Thermo Fisher Scientific) Revenue Growth Rate in Personalized Medicines In Oncology Business (2016-2021)
Figure 69. Fulgent Genetics Revenue Growth Rate in Personalized Medicines In Oncology Business (2016-2021)
Figure 70. Caris Life Sciences Revenue Growth Rate in Personalized Medicines In Oncology Business (2016-2021)
Figure 71. Ariana Pharma Revenue Growth Rate in Personalized Medicines In Oncology Business (2016-2021)
Figure 72. Abbott Laboratories Revenue Growth Rate in Personalized Medicines In Oncology Business (2016-2021)
Figure 73. deCODE genetics Revenue Growth Rate in Personalized Medicines In Oncology Business (2016-2021)
Figure 74. Exagen Inc Revenue Growth Rate in Personalized Medicines In Oncology Business (2016-2021)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed

---